The molecular mechanisms of duodenal tumourigenesis in familial adenomatous polyposis (FAP) and MUTYH-associated polyposis (MAP)

Autor: Meuser, Elena

Duodenal disease has become a leading cause of morbidity and mortality for patients with the inherited syndromes familial adenomatous polyposis (FAP) and -associated polyposis (MAP), yet its underlying mechanisms remain understudied and insufficientl

Externí odkaz: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.768073

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The molecular mechanisms of\ud duodenal tumourigenesis in familial adenomatous polyposis (FAP) and MUTYH-associated polyposis (MAP)

Autor: Meuser, Elena

Duodenal disease has become a leading cause of morbidity and mortality for patients with the inherited syndromes familial adenomatous polyposis (FAP) and -associated polyposis (MAP), yet its underlying mechanisms remain understudied and insufficientl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::3014bd8544e29423e97365ee501f0dce

PIGA Mutations and Glycosylphosphatidylinositol Anchor Dysregulation in Polyposis-Associated Duodenal Tumorigenesis.

Autor: Meuser E; Division of Cancer and Genetics, School of Medicine, Cardiff University, United Kingdom., Chang K; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Walters A; Division of Cancer and Genetics, School of Medicine, Cardiff University, United Kingdom., Hurley JJ; Department of Gastroenterology, Cwm Taf Morgannwg University Health Board, Llantrisant, United Kingdom., West HD; Division of Cancer and Genetics, School of Medicine, Cardiff University, United Kingdom., Perry I; Institute of Life Science 1, Swansea University, Swansea, United Kingdom., Mort M; Division of Cancer and Genetics, School of Medicine, Cardiff University, United Kingdom., Reyes-Uribe L; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Truscott R; Division of Cancer and Genetics, School of Medicine, Cardiff University, United Kingdom., Jones N; Institute of Life Science 1, Swansea University, Swansea, United Kingdom., Lawrence R; Institute of Life Science 1, Swansea University, Swansea, United Kingdom., Jenkins G; Institute of Life Science 1, Swansea University, Swansea, United Kingdom., Giles P; Division of Cancer and Genetics, School of Medicine, Cardiff University, United Kingdom., Dolwani S; Division of Population Medicine, School of Medicine, Cardiff University, United Kingdom., Al-Sarireh B; Department of Gastroenterology, Swansea Bay University Health Board, Swansea, United Kingdom., Hawkes N; Department of Gastroenterology, Cwm Taf Morgannwg University Health Board, Llantrisant, United Kingdom., Short E; Division of Cancer and Genetics, School of Medicine, Cardiff University, United Kingdom.; Department of Cellular Pathology, Swansea Bay University Health Board, Swansea, United Kingdom., Williams GT; Division of Cancer and Genetics, School of Medicine, Cardiff University, United Kingdom., Taggart MW; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Luetchford K; Cellesce Limited, Cardiff Medicentre, Cardiff, United Kingdom., Lynch PM; Department of Gastroenterology, Hepatology and Nutrition, UT MD Anderson Cancer Center, Houston, Texas.; Clinical Cancer Genetics Program, UT MD Anderson Cancer Center, Houston, Texas., Terlouw D; Leiden University Medical Center (LUMC), Department of Clinical Genetics, Leiden, The Netherlands., Nielsen M; Leiden University Medical Center (LUMC), Department of Clinical Genetics, Leiden, The Netherlands., Walton SJ; St Mark's Centre for Familial Intestinal Cancer, St Marks Hospital, London, United Kingdom.; Department of Surgery and Cancer, Faculty of Medicine, Imperial College, London, United Kingdom., Latchford A; St Mark's Centre for Familial Intestinal Cancer, St Marks Hospital, London, United Kingdom.; Department of Surgery and Cancer, Faculty of Medicine, Imperial College, London, United Kingdom., Clark SK; St Mark's Centre for Familial Intestinal Cancer, St Marks Hospital, London, United Kingdom.; Department of Surgery and Cancer, Faculty of Medicine, Imperial College, London, United Kingdom., Sampson JR; Division of Cancer and Genetics, School of Medicine, Cardiff University, United Kingdom., Vilar E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Clinical Cancer Genetics Program, UT MD Anderson Cancer Center, Houston, Texas., Thomas LE; Institute of Life Science 1, Swansea University, Swansea, United Kingdom.

Publikováno v: Molecular cancer research : MCR [Mol Cancer Res] 2024 Jun 04; Vol. 22 (6), pp. 515-523.